Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

Because of misoprostol's known ability to cause cervical dilation, some family planning providers give their patients a dose of this drug prior to insertion. The goal of this study is to evaluate whether misoprostol prior to IUD insertion in nulliparous women eases insertion and decreases pain.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Emory University
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• 18 years

• negative pregnancy test

• no prior pregnancy beyond 19 6/7 weeks

• no pelvic inflammatory disease in last 3 months

• no current cervicitis

• willing to follow up in 1-2 months

Exclusion Criteria:

• active cervical infection

• current pregnancy

• prior pregnancy beyond 19 6/7 weeks

• uterine anomaly

• fibroid uterus distorting uterine cavity

• copper allergy or wilson's disease for ParaGard

• undiagnosed abnormal uterine bleeding

• cervical or uterine cancer

• sepsis associated with the most recent pregnancy

• current breast cancer for levonogestrel IUD

• inflammatory bowel disease

• allergy to misoprostol